Amiloidosis cardiaca secundaria a macroglobulinemia de waldenström

  • Lizbeth Lachira-Yparraguirre
  • , Ali Al-Kassab-córdova
  • , Edgar Quispe-Silvestre
  • , Daniel Enriquez-Vera

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

Resumen

Introduction: Waldenström's macroglobulinemia is a hematological neoplasm belonging to the group of monoclonal gammopathies, which includes systemic symptoms and those related to an increase in M paraprotein. Objective: To describe a case of cardiac amyloidosis associated with macroglobulinemia. Clinical case: Male patient who was admitted for asthenia, dysphonia, and who, during his evolution, developed progressive dyspnea, heart failure and pleural effusion. Additionally, echocardiography showed myocardial granular pattern, while pleural biopsy was positive for Congo red staining. Subsequently, he received treatment with bortezomib, dexamethasone and rituximab, with favorable evolution. Conclusions: In this disease, early diagnosis is an important advantage for survival. Therefore, its management is palliative of cardiac manifestations. The present case shows a diagnostic challenge, in which the less frequent etiologies of heart failure must be taken into account.

Título traducido de la contribuciónCardiac amyloidosis secondary to waldenström macroglobulinemia
Idioma originalEspañol
Número de artículoe1202
Páginas (desde-hasta)1-11
Número de páginas11
PublicaciónRevista Cubana de Hematologia, Inmunologia y Hemoterapia
Volumen36
N.º3
EstadoPublicada - 1 ene. 2020
Publicado de forma externa

Palabras clave

  • Amyloidosis
  • Immunoglobulin light chain amyloidosis
  • Waldenström's macroglobulinemia

Huella

Profundice en los temas de investigación de 'Amiloidosis cardiaca secundaria a macroglobulinemia de waldenström'. En conjunto forman una huella única.

Citar esto